Efficacy of re-treatment with TMC435 as combination therapy in hepatitis C virus-infected patients following TMC435 monotherapy

Gastroenterology

Volumn 143, Issue 5, 2012, Pages

  Lenz, Oliver ^a   De Bruijne, Joep ^b   Vijgen, Leen ^a   Verbinnen, Thierry ^a   Weegink, Christine ^b   Van Marck, Herwig ^a   Vandenbroucke, Ina ^a   Peeters, Monika ^a   Simmen, Kenneth ^a   Fanning, Greg ^a   Verloes, Rene ^a   Picchio, Gaston ^c   Reesink, Hendrik ^b  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Clinical Trial; HCV NS3 4A; Sustained Virologic Response; TMC435 C101

Indexed keywords

EID: 84868028511     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.07.117     Document Type: Article

References (17)

1. I.M. Jacobson N Engl J Med 364 2011 2405 2416
2. F. Poordad N Engl J Med 364 2011 1195 1206
3. J.M. Pawlotsky Hepatology 53 2011 1742 1751
4. C. Sarrazin Gastroenterology 138 2010 447 462
5. S. Zeuzem Hepatology 52 2010 436A Abstract 227
6. R.J. Barnard Hepatology 54 2011 Abstract 164
7. M.W. Fried American Association for the Study of Liver Diseases 2011
8. O. Lenz Antimicrob Agents Chemother 54 2010 1878 1887
9. M. Manns Antivir Ther 16 2011 1021 1033
10. H.W. Reesink Gastroenterology 138 2010 913 921
11. T. Verbinnen J Virol 84 2010 11124 11133
12. O. Lenz American Association for the Study of Liver Diseases 2011
13. P. Marcellin Gastroenterology 140 2011 459 468
14. M. Manns Antivir Ther 16 2011 1021 1033
15. H.W. Reesink Gastroenterology 138 2010 913 921
16. T. Verbinnen J Virol 84 2010 11124 11133
17. D. Ge Nature 461 2009 399 401